Skip to main content
BJA Education logoLink to BJA Education
. 2017 Nov 21;18(1):3–7. doi: 10.1016/j.bjae.2017.09.001

Living well with chronic pain: the role of pain-management programmes

J Gauntlett-Gilbert 1,2,, P Brook 1,3
PMCID: PMC7807918  PMID: 33456788

Key points.

  • Chronic-pain conditions may not be adequately managed by medications alone.

  • Chronic-pain states are driven by well-understood neurophysiological mechanisms and are not ‘psychosomatic’.

  • Patient behaviours and coping styles will determine the functioning and quality of life, more significantly than pain intensity.

  • Pain-management programmes help individuals to focus on functioning and quality of life through self-management, and to broaden the agenda away from pain control alone.

  • Multidisciplinary input is essential; doctors can help by effective preparation of the patient and timely referral, and by avoiding re-medicalization.

Role of pain-management programmes in the care of patients with chronic pain

The clinical management of long-term non-malignant chronic pain can be challenging. The limited number of pharmacological treatments available only helps a proportion of patients, often resulting in tolerance and side-effects with long-term use. Patients can be left with substantial functional disability and poor quality of life, and with their condition causing substantial health-related economic burden.1

In this challenging context, many patients approach pain services hoping for pain elimination, or enduring pain control. They are often searching for an explanation for their pain and may feel that the severity of their symptoms has not been taken seriously2 (unhelpful clinical approaches detailed in Table 1). Clinicians will use evidence-based pharmacological and interventional methods to help; where these are effective in sustainably reducing pain and restoring function, Pain Management Programmes (PMPs) have no role. However, patients who have less long-lasting treatment responses will benefit from a shift in clinical approach. It can help to move away from an emphasis on pharmacological and interventional treatment to a focus on self-managing pain in the long term, and to achieving good functioning and quality of life even if pain persists. This is not easy to achieve, but PMPs can teach the skills to attain this, even where patients’ pain remains poorly controlled by medicines. It is important to introduce patients to self-management philosophy relatively early in their clinical journey, rather than to wait for treatment failure first. Understanding the remit and approach of PMPs allows judicious referral and preparation of patients for this approach.

Table 1.

Clinical strategies and messages around chronic pain

Unhelpful Helpful
Repeated investigations Principled investigations combined with an explanation of why chronic pain can be present without overt pathology
Escalating analgesia focusing on short-term pain relief Clinical focus on long-term functioning; regular medication reviews, removing medicines as important as introducing them
Reassuring results from investigations explained as ‘there is nothing wrong’ Clarify the absence of malignant problems whilst understanding of the distressing persistence of pain symptoms. Explain findings (e.g. ‘degeneration’) in their normative context (e.g. ‘normal age-related degeneration’).
Persuading distressed patients that their pain might be caused by emotions Explain that thoughts and feelings do not cause pain, but that psychological management may be central to living well with it.
Advising patients that they need to ‘learn to live with their problem’ Introduce the idea of self-management carefully with clear examples of how it can be done, and with referral to multidisciplinary input that can support this.

Principles and practical philosophy of pain management

The rationale and philosophy of PMPs rest on (i) a proper understanding of chronic-pain states, (ii) realizing the limits of medical treatment, and (iii) an understanding of what true ‘self-management’ of a chronic condition can look like.

Clinicians and patients need to appreciate an understanding of chronic pain often being driven by central sensitization and altered descending control of nociceptive input.3 Failure to understand this can explain why patients, and often clinicians, cannot make sense of chronic-pain conditions that persist in the absence of an ongoing pathology. This can lead to some clinicians labelling pain as ‘psychosomatic’, and the patient contesting this in a way that impedes treatment and sours clinical relationships.

Extensive research (including in animal models) shows how the pain system can become sensitized, resulting in high levels of pain being evoked spontaneously, or from minimal stimuli. The concept of pain being caused by negative emotions (‘psychosomatic’) has been shown to have poor coherence and validity in the pain literature.4 Of course, there is a significant role for emotions in an individual’s behavioural response to chronic pain, described below, but it is not causal. Instead, chronic pain can be seen as an example of a condition where intense emotional responses can directly worsen symptoms (such as psoriasis), or where negative emotions can make a condition worse by disrupting necessary self-management (such as depression causing poor glycaemic control in diabetes).

Understanding chronic pain correctly allows the patients to make sense of their experience of severe pain in the absence of corresponding tissue damage, and allows them to realize that they are not harming themselves by moving. Much research has shown that fear of pain sensations and the belief that movement is harmful because it is painful (kinesiophobia) result in worse functioning and outcomes,5 reduced movement results in physical deconditioning, and loss of life roles. PMPs can work against this destructive cycle, when the unpleasant but non-damaging nature of chronic-pain sensations is properly understood.

PMPs reframe the clinical approach to chronic pain. An understandable approach to pain is to try to control and reduce it, hoping that this will resolve the difficulties in mood and functioning that came after pain onset. In chronic-pain states, this logic can break down, and can become a barrier to progress. Pain control is not always possible and does not always lead to better functioning. For example, taking a high dose of opioid medication and lying down may result in some pain relief, but not necessarily better long-term functioning.6

Thus, PMPs shift the clinical agenda away from pain control, toward using techniques that allow individuals to function and live well in the face of ongoing pain. A patient’s physical and psychological difficulties in the face of pain can be addressed directly, rather than waiting for pain relief to happen first. Patients are shown how to self-manage their lives, using psychological and physical techniques, in the face of pain, and that this may be more effective than escalating analgesics or repeated interventional techniques. Self-management means a person autonomously being able to become more physically active, manage their moods and behavioural responses, and to set goals and to restructure their lives. It is more than, for example, being ‘given a set of home exercises’ by a professional who is in the ‘expert’ role; true self-management teaches patients to set their own goals, solve their own problems, and achieve such personal effectiveness in the face of their condition that they no longer need regular input from clinicians (Table 2).

Table 2.

Expert vs ‘true’ self-management approaches to pain self-management

Expert driven True self-management
Give a set of home exercises. Teach patient to manage and progress own exercise programme.
Give patient goals and homework. Support patient to develop flexible and independent goal-setting skills.
Solve problems for patient. Where appropriate, refrain from expert problem solving and create an opportunity for patient to use own skills.
Presume that correct information and education will suffice for behaviour change. Give good explanations and information, yet acknowledge that difficult habit change will require difficult repeated practice.
React to crisis/pain flare by taking charge, reassuring, and projecting authority. Stay close to key message that ‘hurt does not equal harm’, project the idea that the patient does not necessarily need ‘rescuing’, and that the patient has behavioural choices and options in the face of pain and difficulty.

Content and techniques involved in a PMP

PMPs are regarded as the ‘treatment of choice’ for chronic pain that has a significant physical, psychological, and social impact.1 National guidance has established the core components required of a PMP.1, 7

Cognitive and behavioural methods

Mood disturbance is common in chronic pain: estimates of the prevalance of depression vary between 30% and 60%.8 It is easy to see how the experience of chronic pain can be frightening and intimidating, and how the associated loss of function can lead to sadness. Also, the base rate of emotional struggles in the general population, irrespective of pain, is high; patients may well have experienced mood disturbance prior to their pain condition. Nonetheless, even understandable emotional reactions can become an independent problem, and can also inhibit effective rehabilitation; people who are low in mood and fearful of movement often struggle to sustain an exercise programme. Thus, psychological techniques, including thought-challenging exposure to difficult tasks, mindfulness, and acceptance, can be used to help an individual’s mood directly and also to facilitate the application of the other PMP skills.

Skills training and activity management

In chronic-pain conditions, personal skills that an individual might have ‘taken for granted’—for example, their ability to plan their day, know their physical limits, and communicate around their needs—can become problematic. PMPs commonly train skills, such as relaxation, mindfulness, and communication. However, activity management—the examination of how people deploy their effort and energy—is probably the most critical aspect of skills training.9 It is understood that people with chronic pain can fall into patterns of avoidance of activity, overexertion, or highly cautious ‘pacing’ where they structure their exertion around minimizing pain levels. None of these are an ideal approach to flexible activity management with pain. PMPs now train various approaches to activity engagement that emphasize self-awareness, realistic approaches to goal setting, and the establishment of a sustainable and increasing level of daily activity.

Physical activity

Exercise or graded-activity increase is a central part of PMP treatment; indeed, there is evidence that exercise alone is beneficial for chronic-pain conditions (e.g. fibromyalgia10). However, exercise is also a challenging proposition for people with chronic pain; it can hurt and not be immediately rewarding. To help an individual learn to self-manage their own exercise programme, there are a range of skills to be taught, including the ability to establish an effective yet sustainable level of exertion, and how to modify and progress exercises to improve functioning. However, nearly all research also emphasizes that sustaining self-guided exercise is a psychological challenge, and that it requires attention to issues, such as motivation and an individual’s beliefs and fears about their pain condition. For example, one model of behaviour change emphasizes that sustained habit change requires capability (exercise skills), motivation, and opportunity (supportive context)11; most PMP approaches also find that addressing pain-related fear is essential. Thus, exercise training requires a broad focus. To help an individual maintain a higher level of activity in the long term, PMPs teach exercise in the context of self-awareness, motivational techniques, and applied problem solving.

Education

PMPs can usefully give patients information on topics, such as medication (and medication reduction); the nature and physiology of chronic pain; issues around sleep; and other topics, such as diet, sex, and the use of aids and adaptations. However, it is widely agreed that education and the provision of information alone are seldom sufficient to achieve behaviour change. It is likely that valuable clinical change comes from individuals changing their attitude and approach to pain (decreasing fear of pain, increasing acceptance, and a focus on valued goals) rather than from being in the possession of more accurate information.12

Outcomes and evidence

There is some consensus on desirable outcome criteria in clinical trials for analgesic agents; domains include pain, physical functioning, emotional functioning, participant-rated improvement, and adverse effects.13 Large surveys show that patients particularly value improvements in functioning and emotional well-being.14 All of these domains, and particularly those favoured by patients, are targeted by PMPs. However, pain reduction is not usually seen as the primary outcome, in contrast to the usual goal of analgesic trials. The evidence supporting PMPs has been evaluated over decades and is regarded as strong, although a recent Cochrane Review has shown that effect sizes are in the small-to-moderate range.15 As chronic pain is a long-standing condition, evidence for enduring treatment effects is particularly valuable; one study of intensive residential PMP treatment has shown that positive effects hold up well, three years after treatment.16 There are strong arguments for the health economic benefits of PMPs, at least when applied relatively early in the course of the condition, where a de-medicalizing self-management approach may obviate the need for expensive interventions, such as surgery or the implantation of a spinal-cord stimulator. A review has indicated that the cost required for functional improvement—measured by the number of dollars required to return an individual to work—favours PMPs above all pharmacological and interventional methods.17

PMPs also, perhaps obviously, have a lower rate of serious medical side-effects than interventional pain-management procedures. Of course, patients can fail to benefit, and even get worse, in the context of the substantial physical and psychological challenges of the PMP. One study of particularly disabled patients undergoing intensive (thus demanding) residential treatment calculated rates of ‘clinically reliable worsening’ at 0–3.4%.18 However, it remains clear that PMPs entail less medical risk for patients than any interventional approach, and cannot—unlike medication—incur greater side-effects with long-term use.

Design and staffing

It takes a certain ‘dose’ of PMP input to reliably achieve good results; the components of this ‘dose’ are the number of hours of input, the range of professionals delivering the programme, and their levels of skill and specialism in pain management. PMPs require a multidisciplinary team; national surveys show that the availability of this provision varies widely.

The British Pain Society states that PMPs should be a minimum of 12 half-days of input (36 h). Minimum staffing includes a doctor, a psychologist, and a physiotherapist; programmes also often incorporate input from occupational therapists, nurses, pharmacists, and clinical-support workers (e.g. healthcare assistants and assistant psychologists). Specific pain-management expertise is required; psychologists should either have this expertise, or be supervised by someone who has, and the Physiotherapy Pain Association has set out core competencies for PMP physiotherapists. Whilst some pain interventions for specific groups of patients can be effective as a uni-disciplinary treatment (e.g. physiotherapist-delivered cognitive-behavioural therapy (CBT) for subacute back pain19), it is recognized that patients with the full picture of pain-related disability and distress require the full package of PMP treatment. In general, more intensive programmes have better outcomes, and there is a recognized danger of ‘watering down’ their delivery, in terms of hours of treatment and staff mix and specialism, such that they become ineffective.

Outpatient PMPs can be delivered in primary- or secondary-care settings. For the most disabled, complex, and refractory patients, specialist residential or inpatient PMPs can be considered. Studies have shown that they are more effective than outpatient programmes,20 but this comparison is not necessarily useful. Instead, it is best that patients with different patterns of difficulty are directed to the different types of approach. For example, where a patient’s physical disability is so severe that they might struggle to attend an outpatient programme, a residential referral may be a good choice. Conversely, a residential programme can be disruptive and unnecessary for a patient who is functioning well enough to benefit as an outpatient.

Referral and preparing the patient

PMPs are an effective, evidence-based treatment for chronic pain; however, to the patients with pain, they can initially seem counter-intuitive, or like an admission of the failure of medical treatment. Embracing PMP philosophy requires, to a degree, acceptance of the fact that pain will persist, that medical treatment will be of limited value, and willingness to practice demanding physical and psychological self-management techniques. Many patients feel that their pain has not been taken seriously, and they have experienced a history of unhelpful clinical treatment, such as detailed in Table 1. Thus, when their treating physician attempts to direct them away from medical solutions to self-management based on the likely persistence of pain (and with a psychological emphasis), it is not hard to see why some resist. Doctors need to be able to explain the rationale of PMPs well, and to refer to them at the right time.

Most PMPs will assess patients for readiness to participate, and the PMP staff can provide advice and guidance about potential suitability. However, it is useful for referring doctors to have some knowledge of positive indicators for referral, beyond the obvious (i.e. absence of treatable disease and safety to exercise). The key factors are readiness to experiment with the PMP agenda, and absence of practical barriers to engagement in a group-based self-management treatment. It is not required that patients should relish the idea of self-management or completely give up their hopes for pain control; rather, they must be willing to try things out, even if they entail emotional and physical challenges. There are practical issues that may render PMP approaches unwise or ill-timed. For example, although PMPs regularly treat patients with depression, there are states of acute psychiatric need (e.g. active psychotic illness, severe post-traumatic stress disorder (PTSD), and certain personality disorders) that would make it unwise for a particular patient to attempt a challenging PMP. Severe cognitive impairment and states of profound physical disability or fatigue may make it impossible for a person to access an effective PMP treatment that requires consistent group attendance (although residential treatment may be an option). Children and adolescents should not be included on adult PMPs, and young adults (e.g. 18–30 yr) may get better results from programmes that target their developmental stage (available at some specialist centres). In contrast, several factors are no longer seen as barriers to treatment, despite having been historically seen as problematic. Older adults, for example, can benefit from treatment, and whilst litigation can have a complicating impact on PMPs (better treatment outcomes may result in less compensation), it is not a necessary reason for exclusion.

Proper explanation and good rationales can prepare patients for PMP treatment. PMPs should be presented as a positive choice that legitimately addresses the long-term challenge of pain, rather than a default response after a period of medical-treatment failure. The psychological aspect of PMPs can require careful explanation, as patients are understandably resistant to the idea that their pain is ‘in their heads’. However, a proper explanation of the nature of chronic pain (as above) can explain why pain persists in the absence of damage without being ‘psychosomatic’. Also, it is easy to explain how any distressing chronic condition, which entails functional limitation and change to life, can come to have an emotional component. Most patients will understand that achieving substantial behaviour change (e.g. losing weight or giving up smoking) is not simply a matter of ‘knowing what to do’; rather, habit change requires an understanding of motivation, beliefs, and patterns of coping that help or hinder. Establishing an exercise habit in the face of pain will be similar. Such analogies can help to explain the psychological aspect of treatment.

Working alongside PMPs and the multidisciplinary team

It is likely that pain doctors will carry on seeing patients during and after PMPs, as symptoms are chronic. Doctors can support the efforts of PMP teams, yet it helps to be aware that medical actions can inadvertently undermine them. It is particularly important to take the correct approach in the period immediately after the PMP. The PMP team will have made efforts to help patients adopt a more active role in their treatment, reduce their dependence on healthcare professionals, and rely more consistently on their own coping resources. This is a challenging philosophy, and is hard to sustain in difficult moments. It is common for patients to have setbacks or flare-ups after PMP treatment. Most of the time, this represents the natural course of the condition, plus the physical and emotional provocation of PMP treatment; it is not necessarily evidence of PMP failure. The best approach for such setbacks is to refer back to the PMP philosophy and to use self-management techniques to approach them. However, the patient may revert to hoping that an expert will step in and resolve the problem, and the doctor may inadvertently undo PMP work by offering to ‘take charge’ with new medical approaches. This usually undermines self-management treatment and re-medicalizes the problem. Of course, sometimes PMP treatment simply does not work. However, in the post-PMP period, it is best to see setbacks as opportunities to practice PMP techniques; doctors should redirect patients to their existing skills, allowing these to have the chance to be practised and to work, and should take care not to re-medicalize matters unless it is clearly indicated.

Declaration of interest

The authors declare that there are no conflicts of interest.

MCQs

The associated MCQs (to support CME/CPD activity) can be accessed at www.bjaed.org/cme/home by subscribers to BJA Education.

Biographies

Jeremy Gauntlett-Gilbert PhD DClinPsy is Principal Clinical Psychologist at the Bath Centre for Pain Services, and an Honorary Fellow at the University of the West of England whose research interests are in the active mechanisms of rehabilitation treatments.

Peter Brook MBBS MRCP FRCA FFPMRCA leads the adult and paediatric chronic pain services at University Hospitals Bristol and is lead for the Complex Regional Pain Syndrome (CRPS) service, the adult inpatient pain management programme and the Breast Radiation Injury Rehabilitation Service at the Royal National Hospital for Rheumatic Diseases in Bath. He is editor of the Oxford Handbook of Pain Management.

Matrix codes: 1A02, 2E03, 3E00

References

  • 1.The British Pain Society . 2013. The British Pain Society guidelines for pain management programmes for adults.https://www.britishpainsociety.org/static/uploads/resources/files/pmp2013_main_FINAL_v6.pdf Available from: [Accessed 22 August 2017] [Google Scholar]
  • 2.Osborn M., Smith J.A. The personal experience of chronic benign lower back pain: an interpretative phenomenological analysis. Br J Health Psychol. 1998;3:65–83. [Google Scholar]
  • 3.Woolf C.J. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:S2–15. doi: 10.1016/j.pain.2010.09.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Crombez G., Beirens K., Van Damme S., Eccleston C., Fontaine J. The unbearable lightness of somatisation: a systematic review of the concept of somatisation in empirical studies of pain. Pain. 2009;145:31–35. doi: 10.1016/j.pain.2009.04.006. [DOI] [PubMed] [Google Scholar]
  • 5.Wideman T.H., Asmundson G.G.J., Smeets R.J.E.M. Rethinking the fear avoidance model: toward a multidimensional framework of pain-related disability. Pain. 2013;154:2262–2265. doi: 10.1016/j.pain.2013.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Martell B.A., O’Connor P.G., Kerns R.D. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116–127. doi: 10.7326/0003-4819-146-2-200701160-00006. [DOI] [PubMed] [Google Scholar]
  • 7.Faculty of Pain Medicine . 2015. Core standards for pain management services in the UK.www.rcoa.ac.uk/system/files/FPM-CSPMS-UK2015.pdf Available from: [Accessed 22 August 2017] [Google Scholar]
  • 8.Goesling J., Clauw D.J., Hassett A.L. Pain and depression: an integrative review of neurobiological and psychological factors. Curr Psychiatry Rep. 2013;15:421. doi: 10.1007/s11920-013-0421-0. [DOI] [PubMed] [Google Scholar]
  • 9.Murphy S.L., Kratz A.L. Activity pacing in daily life: a within-day analysis. Pain. 2014;155:2630–2637. doi: 10.1016/j.pain.2014.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Macfarlane G.J., Kronisch C., Dean L.E. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76:318–328. doi: 10.1136/annrheumdis-2016-209724. [DOI] [PubMed] [Google Scholar]
  • 11.Michie S., van Stralen M.M., West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi: 10.1186/1748-5908-6-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.McCracken L.M., Eccleston C., Bell L. Clinical assessment of behavioral coping responses: preliminary results from a brief inventory. Eur J Pain. 2005;9:69–78. doi: 10.1016/j.ejpain.2004.04.005. [DOI] [PubMed] [Google Scholar]
  • 13.Turk D.C., Dworkin R.H., Burke L.B. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain. 2006;125:208–215. doi: 10.1016/j.pain.2006.09.028. [DOI] [PubMed] [Google Scholar]
  • 14.Turk D.C., Dworkin R.H., Revicki D. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain. 2008;137:276–285. doi: 10.1016/j.pain.2007.09.002. [DOI] [PubMed] [Google Scholar]
  • 15.Morley S., Williams A., Eccleston C. Examining the evidence about psychological treatments for chronic pain: time for a paradigm shift? Pain. 2013;154:1929–1931. doi: 10.1016/j.pain.2013.05.049. [DOI] [PubMed] [Google Scholar]
  • 16.Vowles K.E., McCracken L.M., O’Brien J.Z. Acceptance and values-based action in chronic pain: a three-year follow-up analysis of treatment effectiveness and process. Behav Res Ther. 2011;49:748–755. doi: 10.1016/j.brat.2011.08.002. [DOI] [PubMed] [Google Scholar]
  • 17.Turk D.C., Burwinkle T.M. Clinical outcomes, cost-effectiveness, and the role of psychology in treatments for chronic pain sufferers. Prof Psychol Res Pr. 2005;36:602–610. [Google Scholar]
  • 18.Vowles K., McCracken L.M. Acceptance and values-based action in chronic pain: a study of treatment effectiveness and process. J Consult Clin Psychol. 2008;76:397–407. doi: 10.1037/0022-006X.76.3.397. [DOI] [PubMed] [Google Scholar]
  • 19.Lamb S.E., Hansen Z., Lall R. Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet. 2010;375:916–923. doi: 10.1016/S0140-6736(09)62164-4. [DOI] [PubMed] [Google Scholar]
  • 20.Williams A.C., Richardson P.H., Nicholas M.K. Inpatient vs. outpatient pain management: results of a randomised controlled trial. Pain. 1996;66:13–22. doi: 10.1016/0304-3959(96)02996-X. [DOI] [PubMed] [Google Scholar]

Articles from BJA Education are provided here courtesy of Elsevier

RESOURCES